vs

Side-by-side financial comparison of RCM TECHNOLOGIES, INC. (RCMT) and SI-BONE, Inc. (SIBN). Click either name above to swap in a different company.

RCM TECHNOLOGIES, INC. is the larger business by last-quarter revenue ($86.5M vs $56.3M, roughly 1.5× SI-BONE, Inc.). RCM TECHNOLOGIES, INC. runs the higher net margin — 7.1% vs -2.9%, a 10.0% gap on every dollar of revenue. On growth, SI-BONE, Inc. posted the faster year-over-year revenue change (15.0% vs 12.4%). Over the past eight quarters, SI-BONE, Inc.'s revenue compounded faster (22.0% CAGR vs 9.6%).

Exela Technologies, Inc. is an American business process automation ("BPA") company. It was created with the merger of SourceHOV LCC, Novitex Holdings, Inc. and Quinpario Acquisition Corp. 2.

Bone Clones, Inc. manufactures, distributes, and sells osteological reproductions of human and animal bones. Located in Chatsworth, California, Bone Clones provides these reproductions to museums, universities, medical schools, and other educational institutions.

RCMT vs SIBN — Head-to-Head

Bigger by revenue
RCMT
RCMT
1.5× larger
RCMT
$86.5M
$56.3M
SIBN
Growing faster (revenue YoY)
SIBN
SIBN
+2.6% gap
SIBN
15.0%
12.4%
RCMT
Higher net margin
RCMT
RCMT
10.0% more per $
RCMT
7.1%
-2.9%
SIBN
Faster 2-yr revenue CAGR
SIBN
SIBN
Annualised
SIBN
22.0%
9.6%
RCMT

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
RCMT
RCMT
SIBN
SIBN
Revenue
$86.5M
$56.3M
Net Profit
$6.1M
$-1.6M
Gross Margin
28.1%
79.0%
Operating Margin
9.2%
-4.4%
Net Margin
7.1%
-2.9%
Revenue YoY
12.4%
15.0%
Net Profit YoY
112.9%
63.4%
EPS (diluted)
$0.80
$-0.04

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
RCMT
RCMT
SIBN
SIBN
Q1 26
$86.5M
Q4 25
$56.3M
Q3 25
$70.3M
$48.7M
Q2 25
$78.2M
$48.6M
Q1 25
$84.5M
$47.3M
Q4 24
$76.9M
$49.0M
Q3 24
$60.4M
$40.3M
Q2 24
$69.2M
$40.0M
Net Profit
RCMT
RCMT
SIBN
SIBN
Q1 26
$6.1M
Q4 25
$-1.6M
Q3 25
$2.3M
$-4.6M
Q2 25
$3.8M
$-6.2M
Q1 25
$4.2M
$-6.5M
Q4 24
$2.9M
$-4.5M
Q3 24
$2.7M
$-6.6M
Q2 24
$3.8M
$-8.9M
Gross Margin
RCMT
RCMT
SIBN
SIBN
Q1 26
28.1%
Q4 25
79.0%
Q3 25
27.6%
79.8%
Q2 25
28.5%
79.8%
Q1 25
26.0%
79.7%
Q4 24
28.0%
79.1%
Q3 24
29.6%
79.1%
Q2 24
28.9%
79.0%
Operating Margin
RCMT
RCMT
SIBN
SIBN
Q1 26
9.2%
Q4 25
-4.4%
Q3 25
5.6%
-11.1%
Q2 25
8.4%
-14.4%
Q1 25
7.8%
-15.8%
Q4 24
8.2%
-11.2%
Q3 24
7.3%
-18.9%
Q2 24
8.4%
-25.2%
Net Margin
RCMT
RCMT
SIBN
SIBN
Q1 26
7.1%
Q4 25
-2.9%
Q3 25
3.2%
-9.4%
Q2 25
4.8%
-12.7%
Q1 25
5.0%
-13.8%
Q4 24
3.7%
-9.2%
Q3 24
4.5%
-16.3%
Q2 24
5.4%
-22.4%
EPS (diluted)
RCMT
RCMT
SIBN
SIBN
Q1 26
$0.80
Q4 25
$-0.04
Q3 25
$0.30
$-0.11
Q2 25
$0.50
$-0.14
Q1 25
$0.54
$-0.15
Q4 24
$0.38
$-0.10
Q3 24
$0.35
$-0.16
Q2 24
$0.47
$-0.22

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
RCMT
RCMT
SIBN
SIBN
Cash + ST InvestmentsLiquidity on hand
$2.9M
$42.2M
Total DebtLower is stronger
$35.6M
Stockholders' EquityBook value
$46.0M
$177.5M
Total Assets
$134.4M
$238.6M
Debt / EquityLower = less leverage
0.20×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
RCMT
RCMT
SIBN
SIBN
Q1 26
$2.9M
Q4 25
$42.2M
Q3 25
$1.3M
$26.5M
Q2 25
$5.5M
$34.1M
Q1 25
$5.2M
$41.2M
Q4 24
$4.7M
$34.9M
Q3 24
$3.2M
$30.2M
Q2 24
$3.5M
$25.6M
Total Debt
RCMT
RCMT
SIBN
SIBN
Q1 26
Q4 25
$35.6M
Q3 25
$35.5M
Q2 25
$35.5M
Q1 25
$35.5M
Q4 24
$35.5M
Q3 24
$36.2M
Q2 24
$36.1M
Stockholders' Equity
RCMT
RCMT
SIBN
SIBN
Q1 26
$46.0M
Q4 25
$177.5M
Q3 25
$41.4M
$172.1M
Q2 25
$37.8M
$170.3M
Q1 25
$34.6M
$167.3M
Q4 24
$33.5M
$167.0M
Q3 24
$30.0M
$165.0M
Q2 24
$28.5M
$164.7M
Total Assets
RCMT
RCMT
SIBN
SIBN
Q1 26
$134.4M
Q4 25
$238.6M
Q3 25
$129.8M
$234.3M
Q2 25
$135.6M
$230.9M
Q1 25
$121.0M
$227.3M
Q4 24
$132.1M
$230.4M
Q3 24
$125.5M
$227.0M
Q2 24
$118.3M
$223.8M
Debt / Equity
RCMT
RCMT
SIBN
SIBN
Q1 26
Q4 25
0.20×
Q3 25
0.21×
Q2 25
0.21×
Q1 25
0.21×
Q4 24
0.21×
Q3 24
0.22×
Q2 24
0.22×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
RCMT
RCMT
SIBN
SIBN
Operating Cash FlowLast quarter
$19.0M
$1.7M
Free Cash FlowOCF − Capex
$440.0K
FCF MarginFCF / Revenue
0.8%
Capex IntensityCapex / Revenue
2.3%
Cash ConversionOCF / Net Profit
3.11×
TTM Free Cash FlowTrailing 4 quarters
$-9.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
RCMT
RCMT
SIBN
SIBN
Q1 26
$19.0M
Q4 25
$1.7M
Q3 25
$-1.3M
$2.3M
Q2 25
$-7.9M
$173.0K
Q1 25
$16.7M
$-4.9M
Q4 24
$-1.6M
$1.2M
Q3 24
$-4.3M
$302.0K
Q2 24
$5.7M
$-6.3M
Free Cash Flow
RCMT
RCMT
SIBN
SIBN
Q1 26
Q4 25
$440.0K
Q3 25
$-1.8M
$-620.0K
Q2 25
$-8.4M
$-1.9M
Q1 25
$16.2M
$-7.0M
Q4 24
$-2.6M
$-1.1M
Q3 24
$-4.9M
$-2.7M
Q2 24
$5.3M
$-9.4M
FCF Margin
RCMT
RCMT
SIBN
SIBN
Q1 26
Q4 25
0.8%
Q3 25
-2.5%
-1.3%
Q2 25
-10.7%
-4.0%
Q1 25
19.2%
-14.8%
Q4 24
-3.4%
-2.2%
Q3 24
-8.1%
-6.8%
Q2 24
7.7%
-23.6%
Capex Intensity
RCMT
RCMT
SIBN
SIBN
Q1 26
Q4 25
2.3%
Q3 25
0.7%
6.1%
Q2 25
0.6%
4.3%
Q1 25
0.5%
4.4%
Q4 24
1.3%
4.6%
Q3 24
0.9%
7.5%
Q2 24
0.6%
7.8%
Cash Conversion
RCMT
RCMT
SIBN
SIBN
Q1 26
3.11×
Q4 25
Q3 25
-0.56×
Q2 25
-2.08×
Q1 25
3.98×
Q4 24
-0.57×
Q3 24
-1.58×
Q2 24
1.52×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

RCMT
RCMT

Segment breakdown not available.

SIBN
SIBN

US$53.5M95%
Non Us$2.9M5%

Related Comparisons